Feasibility, tolerance and effects of adding impact loading exercise to pulmonary rehabilitation in people with chronic obstructive pulmonary disease: study protocol for a pilot randomised controlled trial.
Bone health
COPD
Impact loading
Treatable traits
Journal
Pilot and feasibility studies
ISSN: 2055-5784
Titre abrégé: Pilot Feasibility Stud
Pays: England
ID NLM: 101676536
Informations de publication
Date de publication:
03 Aug 2021
03 Aug 2021
Historique:
received:
04
01
2021
accepted:
23
07
2021
entrez:
4
8
2021
pubmed:
5
8
2021
medline:
5
8
2021
Statut:
epublish
Résumé
Chronic obstructive pulmonary disease (COPD) is a disorder linked with a multitude of extra pulmonary manifestations (also known as treatable traits), including low bone mineral density (BMD). To date, no specific guidelines exist for the management of BMD in this population. Impact loading exercise has been identified as an intervention that improves or maintains BMD in other populations. However, the feasibility of and tolerance to impact loading exercise has not been tested in people with COPD. The aim of the proposed study will be to investigate the feasibility and tolerance of adding impact loading exercise to a standard pulmonary rehabilitation programme (PRP) in people with COPD and report its effects on bone health, balance and falls risk. This is a protocol for a pilot feasibility and tolerance randomised controlled trial (RCT). Fifty-eight people with COPD will be randomly allocated, on a 1:1 ratio, to either the experimental or control group. Initially, participants in both groups will complete a standard 8-week (twice-weekly) PRP followed by a 32-week period of maintenance exercises. Over the initial 8-week period, participants allocated to the experimental group will also undertake targeted lower limb resistance exercises and commence a programme of impact loading exercises (e.g. bounding and drop jumps). On completion of the initial 8-week PRP, in addition to the standard maintenance exercises, participants in the experimental group will continue with home-based impact loading exercises, four times a week, for the extra 32 weeks. The primary outcome of this study is feasibility of and tolerance to impact loading exercises. Feasibility will be measured using data collected pertaining to recruitment, withdrawal and completion. Adherence to the exercises will be collected using exercise logs. Tolerance to the exercises will be determined using outcomes to assess pain, recording any adverse effects such as a fall and feedback from the participants in semi-structured interviews on completing of the trial. The effects of the 40-week experimental intervention on bone health, balance and falls risk will be reported. This pilot RCT will test the feasibility and tolerance of an intervention that has never been trialed in people with COPD. It will also provide initial information regarding the size of the effect this intervention has on outcomes such as BMD, balance and falls risk. These data will be critical when designing a definitive RCT to advance this area of research. Australian and New Zealand Clinical Trials Registry (ANZCTR): 12620001085965 (20/10/2020).
Sections du résumé
BACKGROUND
BACKGROUND
Chronic obstructive pulmonary disease (COPD) is a disorder linked with a multitude of extra pulmonary manifestations (also known as treatable traits), including low bone mineral density (BMD). To date, no specific guidelines exist for the management of BMD in this population. Impact loading exercise has been identified as an intervention that improves or maintains BMD in other populations. However, the feasibility of and tolerance to impact loading exercise has not been tested in people with COPD. The aim of the proposed study will be to investigate the feasibility and tolerance of adding impact loading exercise to a standard pulmonary rehabilitation programme (PRP) in people with COPD and report its effects on bone health, balance and falls risk.
METHODS
METHODS
This is a protocol for a pilot feasibility and tolerance randomised controlled trial (RCT). Fifty-eight people with COPD will be randomly allocated, on a 1:1 ratio, to either the experimental or control group. Initially, participants in both groups will complete a standard 8-week (twice-weekly) PRP followed by a 32-week period of maintenance exercises. Over the initial 8-week period, participants allocated to the experimental group will also undertake targeted lower limb resistance exercises and commence a programme of impact loading exercises (e.g. bounding and drop jumps). On completion of the initial 8-week PRP, in addition to the standard maintenance exercises, participants in the experimental group will continue with home-based impact loading exercises, four times a week, for the extra 32 weeks. The primary outcome of this study is feasibility of and tolerance to impact loading exercises. Feasibility will be measured using data collected pertaining to recruitment, withdrawal and completion. Adherence to the exercises will be collected using exercise logs. Tolerance to the exercises will be determined using outcomes to assess pain, recording any adverse effects such as a fall and feedback from the participants in semi-structured interviews on completing of the trial. The effects of the 40-week experimental intervention on bone health, balance and falls risk will be reported.
DISCUSSION
CONCLUSIONS
This pilot RCT will test the feasibility and tolerance of an intervention that has never been trialed in people with COPD. It will also provide initial information regarding the size of the effect this intervention has on outcomes such as BMD, balance and falls risk. These data will be critical when designing a definitive RCT to advance this area of research.
TRIAL REGISTRATION
BACKGROUND
Australian and New Zealand Clinical Trials Registry (ANZCTR): 12620001085965 (20/10/2020).
Identifiants
pubmed: 34344482
doi: 10.1186/s40814-021-00893-1
pii: 10.1186/s40814-021-00893-1
pmc: PMC8330032
doi:
Types de publication
Journal Article
Langues
eng
Pagination
151Informations de copyright
© 2021. The Author(s).
Références
Am J Respir Crit Care Med. 2012 Jul 15;186(2):155-61
pubmed: 22561964
Sports Med. 2012 Apr 1;42(4):301-25
pubmed: 22376192
Respirology. 2015 Oct;20(7):1096-101
pubmed: 26206432
Respir Med. 2007 Jan;101(1):177-85
pubmed: 16677808
Eur Respir J. 2014 Dec;44(6):1447-78
pubmed: 25359356
Eur Respir J. 2014 Dec;44(6):1428-46
pubmed: 25359355
PLoS One. 2013 Apr 05;8(4):e60532
pubmed: 23585837
N Z Med J. 2001 Oct 12;114(1141):447-9
pubmed: 11700772
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Age Ageing. 2009 Jan;38(1):40-6
pubmed: 19141507
BJU Int. 2019 Feb;123(2):261-269
pubmed: 30239116
Eur J Epidemiol. 2008;23(2):115-22
pubmed: 18038248
J Am Geriatr Soc. 2014 Mar;62(3):470-5
pubmed: 24617970
Menopause. 2013 Nov;20(11):1216-26
pubmed: 24149921
Am J Respir Crit Care Med. 2004 Dec 15;170(12):1302-9
pubmed: 15374846
Thorax. 1999 Jul;54(7):581-6
pubmed: 10377201
Physiotherapy. 2011 Dec;97(4):284-90
pubmed: 22051584
Arch Osteoporos. 2017 Dec;12(1):43
pubmed: 28425085
J Clin Epidemiol. 2001 Aug;54(8):837-44
pubmed: 11470394
J Bone Miner Metab. 2010 May;28(3):251-67
pubmed: 20013013
J Gerontol A Biol Sci Med Sci. 1995 Jan;50A(1):M28-34
pubmed: 7814786
Med Sci Sports Exerc. 1982;14(5):377-81
pubmed: 7154893
Cochrane Database Syst Rev. 2015 Feb 23;(2):CD003793
pubmed: 25705944
Eur Respir J. 2016 Feb;47(2):410-9
pubmed: 26828055
Psychol Med. 1988 Nov;18(4):1007-19
pubmed: 3078045
Arch Phys Med Rehabil. 2002 Nov;83(11):1566-71
pubmed: 12422327
Eur Respir J. 2009 Jul;34(1):209-18
pubmed: 19567604
Am J Respir Crit Care Med. 2013 Oct 15;188(8):e13-64
pubmed: 24127811
Thorax. 1987 Oct;42(10):773-8
pubmed: 3321537
Pilot Feasibility Stud. 2016 Oct 21;2:64
pubmed: 27965879
Arch Phys Med Rehabil. 2013 Sep;94(9):1784-1799.e7
pubmed: 23632285
Ann Intern Med. 2013 Feb 5;158(3):200-7
pubmed: 23295957
Med Sci Sports Exerc. 2019 Apr;51(4):607-614
pubmed: 30395051
Chest. 2005 Jun;127(6):1960-6
pubmed: 15947308
J Clin Epidemiol. 2011 Oct;64(10):1152-60
pubmed: 21463927
Health Qual Life Outcomes. 2003 Aug 01;1:29
pubmed: 12914662
Respirology. 2016 Jul;21(5):875-82
pubmed: 26916174
Thorax. 2015 Mar;70(3):213-8
pubmed: 25561517
BMJ. 2003 Sep 27;327(7417):712-7
pubmed: 14512478
Respirology. 2010 Nov;15(8):1157-73
pubmed: 20920127
J Clin Epidemiol. 2013 Feb;66(2):197-201
pubmed: 23195919
J Sci Med Sport. 2017 May;20(5):438-445
pubmed: 27840033
J Gerontol A Biol Sci Med Sci. 1998 Jul;53(4):M287-94
pubmed: 18314568